Advanced search
Publication Cover
Leukemia & Lymphoma Volume 42, 2001 - Issue 1-2
Submit an article Journal homepage
77
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Liposomal Daunorubicin (Daunoxome) in Combination with Cyclophosphamide, Vincristine and Prednisolone (COP-X) as Salvage Therapy in Poor-Prognosis Non-Hodgkins Lymphoma

N. C. McBride Departments of Haematology, St Bartholomew's and the Royal London School of Medicine and Dentistry
,
J. D. Cavenagh Departments of Haematology, St Bartholomew's and the Royal London School of Medicine and Dentistry
,
M. C. Ward Departments of Haematology, St Bartholomew's and the Royal London School of Medicine and Dentistry
,
I. Grant King George Ilford
,
S. Schey Guys Hospital London
,
A. Gray Princess Margaret Hospital Swindon
,
A. Hughes Harold Wood
,
M. J. Mills Southend Hospital
,
P. Cervi Basildon Hospital, UK
,
A. C. Newland Departments of Haematology, St Bartholomew's and the Royal London School of Medicine and Dentistry
&
S. M. Kelsey Departments of Haematology, St Bartholomew's and the Royal London School of Medicine and DentistryCorrespondence[email protected]
 show all
Pages 89-98 | Published online: 01 Jul 2009

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Paul L. R Mitchell, Paula Marlton, Andrew Grigg, John F Seymour, Mark Hertzberg, Arno Enno, Richard Herrmann, Rodney Bond & Chris Arthur. (2008) A phase II study of liposomal daunorubicin, in combination with cyclophosphamide, vincristine and prednisolone, in elderly patients with previously untreated aggressive non-Hodgkin lymphoma. Leukemia & Lymphoma 49:5, pages 924-931.
Read now
Peter Borchmann & & Roland Schnell. (2005) The role of pixantrone in the treatment of non-Hodgkin’s lymphoma. Expert Opinion on Investigational Drugs 14:8, pages 1055-1061.
Read now

Articles from other publishers (11)

Zi-Xian Liao, Kuo-Yen Huang, Ivan M. Kempson, Hsin-Jung Li, S.-Ja Tseng & Pan-Chyr Yang. (2020) Nanomodified strategies to overcome EGFR-tyrosine kinase inhibitors resistance in non-small cell lung cancer. Journal of Controlled Release 324, pages 482-492.
Crossref
Samaa Alrushaid, Casey Sayre, Jaime Yáñez, M. Forrest, Sanjeewa Senadheera, Frank Burczynski, Raimar Löbenberg & Neal Davies. (2017) Pharmacokinetic and Toxicodynamic Characterization of a Novel Doxorubicin Derivative. Pharmaceutics 9:4, pages 35.
Crossref
P.-L. Lam, K. K.-H. Lee, Y.-W. Ho, R. S.-M. Wong, S.-W. Tong, C.-H. Cheng, K.-H. Lam, J. C.-O. Tang, Z.-X. Bian, R. Gambari, S. H.-L. Kok & C.-H. Chui. (2014) The development of chitosan based microcapsules as delivery vehicles for orally administered daunorubicin. RSC Advances 4:27, pages 14109.
Crossref
S Lowis, I Lewis, A Elsworth, C Weston, F Doz, G Vassal, R Bellott, J Robert, F Pein, S Ablett, R Pinkerton & D Frappaz. (2006) A phase I study of intravenous liposomal daunorubicin (DaunoXome) in paediatric patients with relapsed or resistant solid tumours. British Journal of Cancer 95:5, pages 571-580.
Crossref
David S. Alberts, Franco M. Muggia, James Carmichael, Eric P. Winer, Mohammad Jahanzeb, Alan P. Venook, Keith M. Skubitz, Edgardo Rivera, Joseph A. Sparano, Nicholas J. Dibella, Simon J. Stewart, John J. Kavanagh & Alberto A. Gabizon. (2004) Efficacy and safety of liposomal anthracyclines in Phase I/II clinical trials. Seminars in Oncology 31, pages 53-90.
Crossref
Giorgio Minotti, Pierantonio Menna, Emanuela Salvatorelli, Gaetano Cairo & Luca Gianni. (2004) Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity. Pharmacological Reviews 56:2, pages 185-229.
Crossref
Guy B. Faguet. 2004. Chronic Lymphocytic Leukemia. Chronic Lymphocytic Leukemia 377 386 .
Apostolia M. Tsimberidou, Hagop M. Kantarjian, Jorge Cortes, Deborah A. Thomas, Stefan Faderl, Guillermo Garcia‐Manero, Srdan Verstovsek, Alessandra Ferrajoli, William Wierda, Yesid Alvarado, Susan M. O'Brien, Maher Albitar, Michael J. Keating & Francis J. Giles. (2003) Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte‐macrophage–colony stimulating factor (GM‐CSF) alternating with methotrexate and cytarabine plus rituximab and GM‐CSF in patients with Richter syndrome or fludarabine‐refractory chronic lymphocytic leukemia. Cancer 97:7, pages 1711-1720.
Crossref
U. Wollina, K. Hohaus, J. Schönlebe, E. Haroske & E. Köstler. (2003) Liposomal daunorubicin in tumor stage cutaneous T-cell lymphoma. Journal of Cancer Research and Clinical Oncology 129:1, pages 65-69.
Crossref
Nina Griese, Gottfried Blaschke, Joachim Boos & Georg Hempel. (2002) Determination of free and liposome-associated daunorubicin and daunorubicinol in plasma by capillary electrophoresis. Journal of Chromatography A 979:1-2, pages 379-388.
Crossref
. (2002) Current Awareness in Hematological Oncology. Hematological Oncology 20:1, pages 43-50.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.